SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is surging following a strong quarterly beat and raise, with the community actively discussing a shift in market perception as the company rebrands itself as a core player in AI infrastructure. Investors are debating the sustainability of this momentum, weighing concerns about capital intensity and valuation against excitement for a potential long-term CPU renaissance and foundry strategy execution.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is surging to record highs, driven by investor enthusiasm following Intel's earnings beat and broad sector rotation into semiconductor and AI-focused infrastructure plays. While the community is split between bullish sentiment over long-term AI megatrends and concerns regarding potential overvaluation, many traders are closely watching for continued momentum into the upcoming earnings cycle.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

The semiconductor sector's relentless rally has left investors heavily debating the viability of SOXS, as many are struggling with significant losses while the underlying index continues to hit new highs without a meaningful pullback. Community sentiment is deeply divided between those calling for an imminent, violent reversal and others warning that volatility decay makes this inverse, leveraged instrument a dangerous long-term hold.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is currently the focal point of intense community speculation and volatility as it continues a record-breaking rally, with investors debating whether this momentum represents a sustainable super-cycle or a classic blow-off top. The conversation is dominated by contrasting views on the sustainability of semiconductor demand, with many traders riding the parabolic momentum while others aggressively hedge with inverse funds in anticipation of a potential market reversal.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is rallying on massive volume as investors react to the company's confirmed commercial orders from Marvell Technology and its strategic shift to U.S.-based operations. The community is heavily focused on the company's emergence as a vital component in AI data center infrastructure, with traders debating whether this surge represents a sustainable valuation re-rating or a short-lived gamma squeeze triggered by heavy call option activity.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is drawing massive community attention as it navigates a prolonged trading range, with investors closely watching its $5 trillion valuation while debating the stock's potential for a breakout against semiconductor peers like AMD and Intel. While retail sentiment remains deeply polarized between bullish long-term conviction and frustration over the stock's recent lack of momentum, the broader discussion is dominated by the narrative of AI infrastructure build-outs and the ongoing rotation of capital across the chip sector.

Skillz, Inc. operates a mobile gaming platform that connects players in competition. It helps developers build franchises by enabling social competition in their games. Skillz hosts casual esports tournaments for mobile players worldwide. The company was founded by Andrew C Paradise and Casey Chafkin in 2012 and is headquartered in Las Vegas, NV.

Skillz Inc - Ordinary Shares - Class A

Skillz Inc

Skillz Inc. is experiencing extreme volatility and massive trading volume following a jury verdict that awarded the company over $1 billion in damages and disgorgement against a rival for fraudulent bot usage. The community is heavily focused on the potential for a major short squeeze due to the company's tight float and the significant legal catalyst, with traders debating whether to hold for triple-digit gains or exit into the intense retail-driven momentum.

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group (CAR) is seeing extreme volatility as investors grapple with a massive sell-off following a rapid price surge, sparking intense debate over whether the stock is undergoing a fundamental correction or setting up for another short squeeze. The community remains deeply divided, with bears pointing to the company's significant debt load and potential securities investigations as red flags, while some bulls are actively searching for signs of a technical rebound or renewed institutional buying interest.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Berkeley Heights, NJ.

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals is trending due to the ongoing rollout of its fibromyalgia treatment, Tonmya, with the community closely tracking prescription data and pharmacy benefit manager coverage expansions. While some investors express deep frustration over historical dilution and the potential for future reverse splits, others remain focused on the potential for long-term revenue growth as the company navigates this commercial launch phase.

Dumb SEND IT

Community members are actively rallying behind $DSIT, viewing the current market cap as an early entry opportunity before the token potentially graduates on its bonding curve. Discussion is heavily focused on the developer's engagement through airdrops and a collective push to drive volume and increase holder counts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Roth Mkm Reiterates Buy Rating for Equillium (NASDAQ:EQ)

Roth Mkm restated a "buy" rating and set a $12.00 target price on shares of Equillium in a research report on Friday...

Equillium (NASDAQ:EQ) Earns Buy Rating from Analysts at B. Riley Financial

B. Riley Financial began coverage on Equillium in a research note on Thursday. They issued a "buy" rating and a $6.00 price target for the company...

Short Interest in Equillium, Inc. (NASDAQ:EQ) Grows By 36.6%

Equillium, Inc. (NASDAQ:EQ - Get Free Report) was the target of a large increase in short interest during the month of March. As of March 31st, there was short interest totaling 2,727,834 shares, an...

Aberdeen Group plc Grows Stake in Equillium, Inc. $EQ

Aberdeen Group plc grew its holdings in Equillium, Inc. (NASDAQ:EQ - Free Report) by 523.6% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned...

Equillium, Inc. (NASDAQ:EQ) Given Average Rating of "Hold" by Brokerages

Equillium, Inc. (NASDAQ:EQ - Get Free Report) has received a consensus recommendation of "Hold" from the five analysts that are covering the company, Marketbeat reports. One analyst has rated the...

Cantor Fitzgerald Begins Coverage on Equillium (NASDAQ:EQ)

Cantor Fitzgerald initiated coverage on Equillium in a report on Tuesday. They set an "overweight" rating and a $10.00 price objective on the stock...

Equillium (NASDAQ:EQ) Issues Quarterly Earnings Results, Beats Estimates By $0.10 EPS

Equillium (NASDAQ:EQ - Get Free Report) issued its earnings results on Wednesday. The company reported ($0.04) earnings per share for the quarter, topping analysts' consensus estimates of ($0.14) by...

Equillium (EQ) Expected to Announce Earnings on Thursday

Equillium (NASDAQ:EQ) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 26. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-3-26-equillium-inc-stock...

Equillium (NASDAQ:EQ) COO Sells $300,780.00 in Stock

Equillium, Inc. (NASDAQ:EQ - Get Free Report) COO Christine Zedelmayer sold 120,312 shares of the company's stock in a transaction that occurred on Friday, March 13th. The stock was sold at an...

Cantor Fitzgerald L. P. Invests $608,000 in Equillium, Inc. $EQ

Cantor Fitzgerald L. P. bought a new stake in Equillium, Inc. (NASDAQ:EQ - Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission...

Equillium, Inc. is a clinical-stage biotechnology company that engages in the development of novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need. Its product pipeline includes EQ001, which is a monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. The company was founded by Daniel Mark Bradbury, Bruce D. Steel, and Stephen Connelly in March 2017 and is headquartered in La Jolla, CA.

EQ
Equillium Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest EQ News

EQEquillium Inc